Trial · NCT02408484
Results by group53
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 53
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Maximum Clot Firmness (MCF) for the First Bleeding Episode for Each Patients and for All Bleeding Episodes | Change in MCF for the firstBLEED Population | 3.1 | Standard Deviation 1.96 | millimeter (mm) | |
| Change in Maximum Clot Firmness (MCF) for the First Bleeding Episode for Each Patients and for All Bleeding Episodes | Change in MCF for the BLEED Population | 3.3 | Standard Deviation 1.77 | millimeter (mm) | |
| Change in the Fibrinogen Level for All Bleeding Episodes up to 1 Hour-post Infusion for the First Bleeding Episode and All Bleeding Episodes | Change in Fibrinogen Level for the firstBLEED Population | 98.9 | Standard Deviation 13.56 | fibrinogen level (mg/dL) | |
| Change in the Fibrinogen Level for All Bleeding Episodes up to 1 Hour-post Infusion for the First Bleeding Episode and All Bleeding Episodes | Change in Fibrinogen Level for the BLEED Population | 98.1 | Standard Deviation 13.33 | fibrinogen level (mg/dL) | |
| Incremental in Vivo Recovery Following the First Infusion of Octafibrin Administration for the Treatment of the First Bleeding Episode and of All Bleeding Episodes | Incremental IVR Response for the firstBLEED Population | 1.5 | Standard Deviation 0.29 | (mg/dL)/(mg/kg) | |
| Incremental in Vivo Recovery Following the First Infusion of Octafibrin Administration for the Treatment of the First Bleeding Episode and of All Bleeding Episodes | Incremental IVR Response for the BLEED Population | 1.5 | Standard Deviation 0.34 | (mg/dL)/(mg/kg) | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | Investigator | Excellent | 7 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | IDMEAC | Excellent | 8 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | Investigator | Good | 1 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | IDMEAC | Good | 2 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | Investigator | Moderate | 1 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | IDMEAC | Moderate | 0 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | Investigator | None | 1 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Four-point Haemostatic Efficacy Scale | IDMEAC | None | 0 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Two-point Haemostatic Efficacy Scale | Investigator | Success | 8 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Two-point Haemostatic Efficacy Scale | IDMEAC | Success | 10 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Two-point Haemostatic Efficacy Scale | Investigator | Failure | 2 | Number of bleeding episodes | |
| Efficacy of Octafibrin in All Bleeding Episodes Based on a Two-point Haemostatic Efficacy Scale | IDMEAC | Failure | 0 | Number of bleeding episodes | |
| Efficacy of Octafibrin in Surgical Prophylaxis Based on a Four-point Haemostatic Efficacy Scale | Surgeon | Excellent | 3 | Number of surgeries | |
| Efficacy of Octafibrin in Surgical Prophylaxis Based on a Four-point Haemostatic Efficacy Scale | IDMEAC | Excellent | 3 | Number of surgeries |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02408484/results?page=2